Associations between plasma natriuretic peptides and echocardiographic abnormalities in geriatric outpatients

Joost H W Rutten1, Nathalie van der Velde, Tischa J M van der Cammen

  • 1Department of Internal Medicine, Section of Vascular Medicine, Erasmus University Medical Center, 's-Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands. j.rutten@erasmusmc.nl

Insights

Elevated B-type natriuretic peptide (BNP) and atrial natriuretic peptide (ANP) levels indicate cardiac abnormalities in older adults. BNP is a stronger predictor of cardiac issues than ANP in geriatric outpatients.

Area of Science:

  • Cardiology
  • Geriatrics
  • Biomarkers

Background:

  • Cardiac dysfunction diagnosis in the elderly is challenging.
  • Natriuretic peptides are emerging biomarkers for heart failure detection.

Purpose of the Study:

  • To investigate the association between natriuretic peptide levels and echocardiographic findings in geriatric outpatients.
  • To compare the diagnostic utility of atrial natriuretic peptide (ANP) and B-type natriuretic peptide (BNP) in this population.

Main Methods:

  • Two-dimensional transthoracic echocardiography was performed on 209 community-dwelling geriatric outpatients (≥65 years).
  • Plasma levels of ANP and BNP were measured.
  • Statistical analysis correlated peptide levels with echocardiographic abnormalities.

Main Results:

  • BNP, but not ANP, correlated with left ventricular dysfunction and mass.
  • Both ANP and BNP correlated with left atrial dimension and valvular lesions.
  • Higher tertiles of both peptides were associated with increased risk of echocardiographic abnormalities, with higher odds ratios for BNP.

Conclusions:

  • Elevated plasma levels of BNP and ANP are closely linked to cardiac abnormalities in elderly individuals.
  • BNP shows a stronger association with cardiac abnormalities than ANP in this cohort.
  • BNP measurement is preferred over ANP for detecting cardiac abnormalities in geriatric outpatients.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...